89 related articles for article (PubMed ID: 7574346)
1. [Current treatment of cancers of the anal canal].
Gérard JP; Romestaing P; Ardiet JM; Trillet Lenoir V; Rocher FP; Baron MH; Buatois F
Ann Chir; 1995; 49(5):363-8; discussion 368-72. PubMed ID: 7574346
[TBL] [Abstract][Full Text] [Related]
2. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
3. [A case of effective chemoradiotherapy using S-1 and CDDP for left inguinal lymph node metastasis of anal canal carcinoma].
Kuga Y; Tanaka T; Arita M; Usui Y; Okanobu H; Numata Y; Miwata T; Yoshimi S; Murakami E; Moriya T; Ohya T; Nishida T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1923-5. PubMed ID: 19920402
[TBL] [Abstract][Full Text] [Related]
4. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative chemoradiation (XELOX/RT) therapy for anal canal adenocarcinoma with the metastasis to inguinal lymph node].
Makino S; Ide Y; Murata K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2048-50. PubMed ID: 22202280
[TBL] [Abstract][Full Text] [Related]
6. Management of anal canal cancer.
Sato H; Koh PK; Bartolo DC
Dis Colon Rectum; 2005 Jun; 48(6):1301-15. PubMed ID: 15793642
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and treatment of 49 patients with anal canal adenocarcinoma].
Li LR; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Lu ZH; Ding PR
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):402-4. PubMed ID: 17043960
[TBL] [Abstract][Full Text] [Related]
8. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ
Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
[TBL] [Abstract][Full Text] [Related]
10. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
11. [The role of radical surgery in the treatment of epidermoid carcinoma of the anal canal].
Luna-Pérez P; Fernández A; Labastida S; Acevedo C; Torres S; Padilla R; Herrera Ornelas L
Gac Med Mex; 1994; 130(5):380-5. PubMed ID: 7607369
[TBL] [Abstract][Full Text] [Related]
12. [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].
Faivre C; Rougier P; Ducreux M; Mitry E; Lusinchi A; Lasser P; Elias D; Eschwege F
Bull Cancer; 1999 Oct; 86(10):861-5. PubMed ID: 10572237
[TBL] [Abstract][Full Text] [Related]
13. [Cancer of the anal canal].
Ruíz Molina JM; Gómez Aceytuno R; Gallardo Rincón D; Herrera R; Mondragón Sánchez RJ; Oñate Ocaña LF; Aiello Crocifoglio V
Rev Gastroenterol Mex; 1997; 62(3):184-8. PubMed ID: 9480525
[TBL] [Abstract][Full Text] [Related]
14. Cancer of the anal canal and local control.
Valentini V; Mantello G; Luzi S; Macchia G; Manfrida S; Smaniotto D
Rays; 1998; 23(3):586-94. PubMed ID: 9932478
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma of the anal margin.
Newlin HE; Zlotecki RA; Morris CG; Hochwald SN; Riggs CE; Mendenhall WM
J Surg Oncol; 2004 May; 86(2):55-62; discussion 63. PubMed ID: 15112245
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of anal cancer in Trøndelag].
Haaverstad R; Myrvold HE; Klepp O; Sundstrøm S; Aase S; Langmark F
Tidsskr Nor Laegeforen; 1993 Nov; 113(28):3454-7. PubMed ID: 8273074
[TBL] [Abstract][Full Text] [Related]
17. Organ preservation in carcinoma of the anal canal.
Valentini V; Mantello G; Leone MV; Luzi S; Turriziani A
Rays; 1997; 22(3):447-53. PubMed ID: 9446949
[TBL] [Abstract][Full Text] [Related]
18. [The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy].
Valentini V; Mantello G; Luzi S; Genovesi D; Smaniotto D; Mantini G; Coco C; Ratto C; Sofo L; Cellini N
Radiol Med; 1997 Apr; 93(4):451-6. PubMed ID: 9244925
[TBL] [Abstract][Full Text] [Related]
19. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment of basaloid anal carcinoma using cisplatin, 5-fluorouracil and resection of hepatic metastasis.
Gurfinkel R; Walfisch S
Tech Coloproctol; 2005 Dec; 9(3):235-6. PubMed ID: 16328122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
